微信公众号

官网二维码

中国癌症防治杂志 ›› 2025, Vol. 17 ›› Issue (3): 320-327.doi: 10.3969/j.issn.1674-5671.2025.03.09

• 其他消化系统肿瘤专栏 • 上一篇    下一篇

影像组学与人工智能在局部晚期直肠癌新辅助放化疗中的应用进展

  

  1. 浙江省肿瘤医院/中国科学院杭州医学研究所;浙江省放射肿瘤学重点实验室;南京医科大学公共卫生学院;天津医科大学肿瘤医院放射治疗科/国家恶性肿瘤临床医学研究中心/天津市肿瘤防治重点实验室/天津市恶性肿瘤临床医学研究中心;荷兰马斯特里赫特大学医学中心GROW肿瘤学院放射肿瘤学系
  • 出版日期:2025-06-25 发布日期:2025-07-10
  • 通讯作者: 朱骥 E-mail:leo.zhu@126.com
  • 基金资助:
    国家自然科学基金项目(82303672)

Advances in the application of radiomics and artificial intelligence in chemoradiotherapy for locally advanced  rectal cancer

  • Online:2025-06-25 Published:2025-07-10

摘要: 术前新辅助放化疗(neoadjuvant chemoradiotherapy,nCRT)后进行全直肠系膜切除术(total mesorectal excision,TME)已成为局部晚期直肠癌(locally advanced rectal cancer,LARC)患者的标准治疗方案。nCRT可显著缩小肿瘤体积,降低复发风险。高效、准确地预测接受nCRT的LARC患者的疗效、预后及毒性反应,对于优化个体化诊疗策略至关重要。随着对影像组学的深入研究与人工智能技术的快速发展,影像组学与人工智能技术在医学影像分析方面亦显示出极大的潜力。本文就影像组学与人工智能在LARC患者接受nCRT治疗中的应用进展与局限性进行综述,旨在为个体化诊断和治疗策略的选择提供参考,并探讨未来的研究方向。

关键词: 局部晚期直肠癌, 新辅助放化疗, 影像组学, 人工智能

Abstract: Preoperative neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) has become the standard treatment protocol for patients with locally advanced rectal cancer (LARC). nCRT significantly reduces tumor volume and decreases the likelihood of recurrence. Accurate prediction of  treatment efficacy, prognosis, and toxicity in LARC patients undergoing nCRT is crucial for optimizing individualized diagnostic and therapeutic strategies. With the  advancement of radiomics and the rapid development of artificial intelligence technology, both fields have demonstrated substantial potential in medical image analysis. This article reviews the progress and limitations of radiomics and artificial intelligence in LARC patients undergoing nCRT, with the aim of providing a reference for development of individualized diagnostic and treatment strategies and exploring future research endeavors.

Key words: Locally advanced rectal cancer, Neoadjuvant chemoradiotherapy, Radiomics, Artificial intelligence

中图分类号: 

  • R735.3